• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Plasminogen activator and its inhibitor in the experimental corneal wound.

作者信息

Tervo T, Tervo K, van Setten G B, Virtanen I, Tarkkanen A

机构信息

Department of Ophthalmology, University of Helsinki, Finland.

出版信息

Exp Eye Res. 1989 Mar;48(3):445-9. doi: 10.1016/s0014-4835(89)80012-0.

DOI:10.1016/s0014-4835(89)80012-0
PMID:2494049
Abstract

Anterior keratectomy was performed to 10 eyes of 8 adult rabbits. The animals were killed 3-24 hr after wound closure. The corneas were excised and subjected to histochemical demonstration of urokinase-type plasminogen activator (u-PA), tissue-type PA (t-PA) and plasminogen activator inhibitor [PAI-1) using commercial antibodies. A strong immunoreaction for u-PA, a weaker reaction for PAI-1 and a very weak t-PA-like immunoreaction appeared in the anterior stroma of the wounded area. None of the antisera used showed any immunostaining in the cornea outside the wound. The role of the plasminogen activator-plasmin system in the healing of the corneal wound is discussed.

摘要

相似文献

1
Plasminogen activator and its inhibitor in the experimental corneal wound.
Exp Eye Res. 1989 Mar;48(3):445-9. doi: 10.1016/s0014-4835(89)80012-0.
2
Production of proteases type plasminogen activator and their inhibitor in cornea.角膜中纤溶酶原激活物型蛋白酶及其抑制剂的产生。
Biochem Biophys Res Commun. 1989 May 15;160(3):1021-5. doi: 10.1016/s0006-291x(89)80104-4.
3
Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.与纤维蛋白结合的1型纤溶酶原激活物抑制剂(PAI-1)与组织型纤溶酶原激活物(t-PA)或尿激酶型纤溶酶原激活物(u-PA)之间的相互作用。t-PA的指状结构域和kringle-2结构域介导t-PA/PAI-1复合物与纤维蛋白的结合。
J Clin Invest. 1989 Aug;84(2):647-55. doi: 10.1172/JCI114211.
4
Pathogenesis of corneal epithelial defects: role of plasminogen activator.角膜上皮缺损的发病机制:纤溶酶原激活剂的作用
Curr Eye Res. 1991 May;10(5):381-98. doi: 10.3109/02713689109001747.
5
Fibrinolytic activity and species of plasminogen activator in human tears.人泪液中纤溶活性及纤溶酶原激活物种类
Exp Eye Res. 1988 Feb;46(2):131-7. doi: 10.1016/s0014-4835(88)80071-x.
6
Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.U-937单核吞噬细胞对尿激酶型纤溶酶原激活剂和纤溶酶原激活剂抑制剂-2表达的调节作用。1α,25-二羟基维生素D3和佛波酯的影响。
J Immunol. 1988 Oct 15;141(8):2693-8.
7
Hormonal regulation of the release of plasminogen activators and of a specific activator inhibitor from endometrial tissue in culture.培养的子宫内膜组织中纤溶酶原激活剂及一种特异性激活剂抑制剂释放的激素调节。
Proc Soc Exp Biol Med. 1986 Sep;182(4):419-24. doi: 10.3181/00379727-182-42360.
8
The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance.纤溶酶原激活物抑制剂1与纤溶酶原激活物(组织型和尿激酶型)及纤维蛋白的相互作用:相互作用位点的定位及生理相关性
Blood. 1991 Jul 15;78(2):401-9.
9
Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines.肿瘤坏死因子-α调节人肿瘤细胞系中尿激酶型纤溶酶原激活物和1型纤溶酶原激活物抑制剂的mRNA。
Mol Cell Endocrinol. 1989 Jan;61(1):87-96. doi: 10.1016/0303-7207(89)90192-5.
10
Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma.纤溶酶原激活剂及纤溶酶原激活剂抑制剂1在去分化软骨肉瘤中的表达
Cancer. 1997 Jan 1;79(1):53-8.

引用本文的文献

1
Defective perlecan-associated basement membrane regeneration and altered modulation of transforming growth factor beta in corneal fibrosis.缺陷性聚糖蛋白聚糖相关基底膜再生和转化生长因子β在角膜纤维化中的改变调节。
Cell Mol Life Sci. 2022 Feb 21;79(3):144. doi: 10.1007/s00018-022-04184-7.
2
Thrombin alters the synthesis and processing of CYR61/CCN1 in human corneal stromal fibroblasts and myofibroblasts through multiple distinct mechanisms.凝血酶通过多种不同机制改变人角膜基质成纤维细胞和肌成纤维细胞中CYR61/CCN1的合成与加工。
Mol Vis. 2020 Jul 29;26:540-562. eCollection 2020.
3
Role of protease-activated receptors 2 (PAR2) in ocular infections and inflammation.
蛋白酶激活受体2(PAR2)在眼部感染和炎症中的作用。
Receptors Clin Investig. 2014;1(6). doi: 10.14800/rci.291.
4
Hyperglycemia-suppressed expression of Serpine1 contributes to delayed epithelial wound healing in diabetic mouse corneas.高血糖抑制的丝氨酸蛋白酶抑制剂1(Serpine1)表达导致糖尿病小鼠角膜上皮伤口愈合延迟。
Invest Ophthalmol Vis Sci. 2015 May;56(5):3383-92. doi: 10.1167/iovs.15-16606.
5
Protease-activated receptor 2 (PAR2) is upregulated by Acanthamoeba plasminogen activator (aPA) and induces proinflammatory cytokine in human corneal epithelial cells.蛋白酶激活受体 2(PAR2)可被棘阿米巴原虫纤溶酶原激活物(aPA)上调,并在人角膜上皮细胞中诱导促炎细胞因子。
Invest Ophthalmol Vis Sci. 2014 May 29;55(6):3912-21. doi: 10.1167/iovs.14-14486.
6
Pharmacokinetics of polyvalent proteinase inhibitor (aprotinin) in eye tissues.多价蛋白酶抑制剂(抑肽酶)在眼组织中的药代动力学。
Doc Ophthalmol. 1994;85(3):275-80. doi: 10.1007/BF01664935.
7
Tear plasminogen activators--indicators of epithelial cell destruction. The effect of scraping, n-heptanol debridement, and alkali burn of the cornea on the plasminogen activator activity of rabbit tears.泪液纤溶酶原激活剂——上皮细胞破坏的指标。刮伤、正庚醇清创术及角膜碱烧伤对兔泪液纤溶酶原激活剂活性的影响。
Int Ophthalmol. 1991 Nov;15(6):363-9. doi: 10.1007/BF00137946.